Pützer BM - Search Results

1

Hybrid modeling of the crosstalk between signaling and transcriptional networks using ordinary differential equations and multi-valued logic.

Khan FM, Schmitz U, Nikolov S, Engelmann D, Pützer BM, Wolkenhauer O, Vera J. Khan FM, et al. Among authors: putzer bm. Biochim Biophys Acta. 2014 Jan;1844(1 Pt B):289-98. doi: 10.1016/j.bbapap.2013.05.007. Epub 2013 May 18. Biochim Biophys Acta. 2014. PMID: 23692959

2

DNp73 a matter of cancer: mechanisms and clinical implications.

Buhlmann S, Pützer BM. Buhlmann S, et al. Among authors: putzer bm. Biochim Biophys Acta. 2008 Apr;1785(2):207-16. doi: 10.1016/j.bbcan.2008.01.002. Epub 2008 Feb 12. Biochim Biophys Acta. 2008. PMID: 18302944 Review.

3

Transcriptome analysis in mouse tumors induced by Ret-MEN2/FMTC mutations reveals subtype-specific role in survival and interference with immune surveillance.

Engelmann D, Koczan D, Ricken P, Rimpler U, Pahnke J, Li Z, Pützer BM. Engelmann D, et al. Among authors: putzer bm. Endocr Relat Cancer. 2009 Mar;16(1):211-24. doi: 10.1677/ERC-08-0158. Epub 2008 Nov 4. Endocr Relat Cancer. 2009. PMID: 18984779

4

Functional interplay between E2F1 and chemotherapeutic drugs defines immediate E2F1 target genes crucial for cancer cell death.

Engelmann D, Knoll S, Ewerth D, Steder M, Stoll A, Pützer BM. Engelmann D, et al. Among authors: putzer bm. Cell Mol Life Sci. 2010 Mar;67(6):931-48. doi: 10.1007/s00018-009-0222-0. Epub 2009 Dec 15. Cell Mol Life Sci. 2010. PMID: 20013022 Free PMC article.

5

E2F1 in melanoma progression and metastasis.

Alla V, Engelmann D, Niemetz A, Pahnke J, Schmidt A, Kunz M, Emmrich S, Steder M, Koczan D, Pützer BM. Alla V, et al. Among authors: putzer bm. J Natl Cancer Inst. 2010 Jan 20;102(2):127-33. doi: 10.1093/jnci/djp458. Epub 2009 Dec 21. J Natl Cancer Inst. 2010. PMID: 20026813

6

Checks and balances: E2F-microRNA crosstalk in cancer control.

Emmrich S, Pützer BM. Emmrich S, et al. Among authors: putzer bm. Cell Cycle. 2010 Jul 1;9(13):2555-67. doi: 10.4161/cc.9.13.12061. Cell Cycle. 2010. PMID: 20581444 Review.

7

Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance.

Engelmann D, Pützer BM. Engelmann D, et al. Among authors: putzer bm. Drug Resist Updat. 2010 Aug-Oct;13(4-5):119-31. doi: 10.1016/j.drup.2010.06.001. Epub 2010 Aug 1. Drug Resist Updat. 2010. PMID: 20675184 Review.

8

The dark side of E2F1: in transit beyond apoptosis.

Engelmann D, Pützer BM. Engelmann D, et al. Among authors: putzer bm. Cancer Res. 2012 Feb 1;72(3):571-5. doi: 10.1158/0008-5472.CAN-11-2575. Cancer Res. 2012. PMID: 22298593 Review.

9

E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry.

Alla V, Kowtharapu BS, Engelmann D, Emmrich S, Schmitz U, Steder M, Pützer BM. Alla V, et al. Among authors: putzer bm. Cell Cycle. 2012 Aug 15;11(16):3067-78. doi: 10.4161/cc.21476. Epub 2012 Aug 8. Cell Cycle. 2012. PMID: 22871739 Free PMC article.

10

E2F1 apoptosis counterattacked: evil strikes back.

Pützer BM, Engelmann D. Pützer BM, et al. Trends Mol Med. 2013 Feb;19(2):89-98. doi: 10.1016/j.molmed.2012.10.009. Epub 2012 Dec 5. Trends Mol Med. 2013. PMID: 23219173 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters